All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Additional factors underlying pacing induced cardiomyopathy in patients underwent right ventricular pacing and his bundle pacing. Author's reply

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064173%3A_____%2F24%3A43926201" target="_blank" >RIV/00064173:_____/24:43926201 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11120/24:43926201

  • Result on the web

    <a href="https://journals.viamedica.pl/kardiologia_polska/article/view/97882" target="_blank" >https://journals.viamedica.pl/kardiologia_polska/article/view/97882</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.33963/v.kp.97882" target="_blank" >10.33963/v.kp.97882</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Additional factors underlying pacing induced cardiomyopathy in patients underwent right ventricular pacing and his bundle pacing. Author's reply

  • Original language description

    We agree that concomitant diseases such as cardiac sarcoidosis (CS) and amyloidosis (CA) might influence the clinical course of patients with bradycardia. The clinical spectrum of transthyretin cardiac amyloidosis (ATTR-CA) symptoms includes advanced conduction disorders requiring pacemaker implantation. It had been documented that 3%-13% of patients with ATTR-CA had pacemakers implanted before they were diagnosed with CA. However, in the European population, the prevalence of ATTR-CA in pacemaker patients was very low (only 2%). Cardiac sarcoidosis (CS) also leads to advanced symptomatic atrioventricular blocks, and according to Kandolin et al., it was the first symptom in up to 44% of patients with diagnosed CS. However, the prevalence of CS remains very low in the European population, where it is a rare condition. We initiate further diagnostic steps only if other risk factors are present. Therefore, we believe that the low prevalence of these diseases and the randomized study design should not affect the differences in the left ventricular ejection fraction between studied groups. On the other hand, we agree that due to the pathophysiology of the diseases, scanning for CS and CA could be helpful while measuring the markers of collagen metabolism.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30201 - Cardiac and Cardiovascular systems

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2024

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Polish Heart Journal - Kardiologia Polska

  • ISSN

    0022-9032

  • e-ISSN

    1897-4279

  • Volume of the periodical

    82

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    PL - POLAND

  • Number of pages

    2

  • Pages from-to

    117-118

  • UT code for WoS article

    001162376000001

  • EID of the result in the Scopus database

    2-s2.0-85183965101